Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity.

Chou SH, Shetty AV, Geng Y, Xu L, Munirathinam G, Pipathsouk A, Tan I, Morris T, Wang B, Chen A, Zheng G.

Cancer Immunol Immunother. 2013 Mar;62(3):597-603. doi: 10.1007/s00262-012-1364-8. Epub 2012 Nov 4.

PMID:
23124508
[PubMed - indexed for MEDLINE]
2.

Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice.

Iigo M, Nishikata K, Nakajima Y, Moriyama M.

Jpn J Cancer Res. 1989 Jun;80(6):554-61.

PMID:
2527216
[PubMed - indexed for MEDLINE]
3.

Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle.

Yao H, Ng SS, Huo LF, Chow BK, Shen Z, Yang M, Sze J, Ko O, Li M, Yue A, Lu LW, Bian XW, Kung HF, Lin MC.

Mol Cancer Ther. 2011 Jun;10(6):1082-92. doi: 10.1158/1535-7163.MCT-10-0717. Epub 2011 Apr 25.

PMID:
21518728
[PubMed - indexed for MEDLINE]
Free Article
4.

Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

Murphy WJ, Back TC, Conlon KC, Komschlies KL, Ortaldo JR, Sayers TJ, Wiltrout RH, Longo DL.

J Clin Invest. 1993 Oct;92(4):1918-24.

PMID:
8408644
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, Eisenbach L.

Clin Cancer Res. 2005 Jul 1;11(13):4955-61.

PMID:
16000595
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.

Cao X, Wang Q, Ju DW, Tao Q, Wang J.

J Exp Clin Cancer Res. 1999 Jun;18(2):191-200.

PMID:
10464706
[PubMed - indexed for MEDLINE]
7.

Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function.

de Kroon JF, van Bergen CA, de Paus RA, Kluin-Nelemans HC, Willemze R, Falkenburg JH.

J Immunother. 1997 Mar;20(2):101-10.

PMID:
9087382
[PubMed - indexed for MEDLINE]
8.

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2.

Nishimura T, Togashi Y, Goto M, Yagi H, Uchiyama Y, Hashimoto Y.

Cancer Immunol Immunother. 1986;21(1):12-8.

PMID:
3484674
[PubMed - indexed for MEDLINE]
9.

Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.

Dobrzanski MJ, Reome JB, Dutton RW.

J Immunol. 2001 Jul 1;167(1):424-34.

PMID:
11418679
[PubMed - indexed for MEDLINE]
Free Article
10.

Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.

Harada M, Matsuzaki G, Shinomiya Y, Kurosawa S, Ito O, Okamoto T, Takenoyama M, Sumitika H, Nishimura Y, Nomoto K.

Cancer Immunol Immunother. 1994 May;38(5):332-8.

PMID:
8162615
[PubMed - indexed for MEDLINE]
11.

Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma.

Chang ML, Chen YT, Su YC, Kung JT.

J Biomed Sci. 2003;10(6 Pt 1):644-50.

PMID:
14576467
[PubMed - indexed for MEDLINE]
12.
13.

[Specific antitumor effect of lymphokine-activated lymphocytes obtained from tumor-bearing mice after intratumoral injection of interleukin-2 (IL-2)].

Takahashi M.

Nihon Geka Gakkai Zasshi. 1991 Mar;92(3):247-56. Japanese.

PMID:
2051976
[PubMed - indexed for MEDLINE]
14.

Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.

Pan J, Zhang M, Wang J, Wang Q, Xia D, Sun W, Zhang L, Yu H, Cao X.

J Cancer Res Clin Oncol. 2005 Jul;131(7):468-78. Epub 2005 Feb 12.

PMID:
15711825
[PubMed - indexed for MEDLINE]
15.

Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.

Nishimura F, Dusak JE, Eguchi J, Zhu X, Gambotto A, Storkus WJ, Okada H.

Cancer Res. 2006 Apr 15;66(8):4478-87.

PMID:
16618775
[PubMed - indexed for MEDLINE]
Free Article
16.

Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.

Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP.

Cancer Res. 2010 Sep 1;70(17):6725-34. doi: 10.1158/0008-5472.CAN-10-0735. Epub 2010 Jul 20.

PMID:
20647327
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo.

Usui N, Matsushima K, Pilaro AM, Longo DL, Wiltrout RH.

Biotherapy. 1996;9(4):199-208.

PMID:
9012539
[PubMed - indexed for MEDLINE]
18.

Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.

Kjaergaard J, Peng L, Cohen PA, Drazba JA, Weinberg AD, Shu S.

J Immunol. 2001 Dec 1;167(11):6669-77.

PMID:
11714839
[PubMed - indexed for MEDLINE]
Free Article
19.

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.

Quintarelli C, Vera JF, Savoldo B, Giordano Attianese GM, Pule M, Foster AE, Heslop HE, Rooney CM, Brenner MK, Dotti G.

Blood. 2007 Oct 15;110(8):2793-802. Epub 2007 Jul 17.

PMID:
17638856
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.

Kim TS, Xu WS, Sun T, Cohen EP.

Melanoma Res. 1995 Aug;5(4):217-27.

PMID:
7496156
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk